Patents by Inventor Joseph J. Esposito

Joseph J. Esposito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12292545
    Abstract: The present disclosure describes various embodiments of systems, apparatuses, and methods of monitoring wind and water properties. For one such weather monitoring system, a weather monitoring station comprises an upper mast section having an instrumentation package, wherein the instrumentation package includes an orientation sensor, communications circuitry, a wind velocity sensor, and a control unit that is configured to at least receive sensor data and transmit communication data via the communications circuitry. The weather monitoring station further includes at least one lower mast section that is coupled to the upper mast section, and an anchoring system that is coupled to the lower mast section, wherein the anchoring system includes at least one subsurface anchor for inserting into a ground surface within a littoral zone of a coastal area. Other systems, apparatuses, and methods are also provided.
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: May 6, 2025
    Assignees: University of Florida Research Foundation, Inc., Clarkson University, Woods Hole Oceanographic Institution
    Inventors: Forrest J. Masters, Pedro L. Fernandez-Caban, Brian M. Phillips, Christopher C. Ferraro, Britt Raubenheimer, Wei-Ting Lu, Joseph Alex Esposito
  • Patent number: 7087234
    Abstract: The present invention relates to multivalent recombinant raccoon poxviruses, containing more than one exogenous gene inserted into either the thymidine kinase gene, the hemagglutinin gene, or a combination thereof. Disclosed is the use of the multivalent recombinant raccoon poxviruses as vaccines to immunize felines against subsequent challenge by feline pathogens. Also disclosed is a method of making a multivalent recombinant raccoon poxvirus by a recombination process involving the construction of an insertion vector into which the exogenous genes are inserted, and flanking the inserted genes are sequences which can recombine into the raccoon poxvirus thymidine kinase gene, or the hemagglutinin gene, or a combination thereof; introducing both the insertion vector containing the exogenous genes, and raccoon poxvirus into susceptible host cells; and selecting the recombinant raccoon poxvirus from the resultant plaques.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: August 8, 2006
    Assignees: Cornell Research Foundation, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Fred W. Scott, Christopher K. Ngichabe, Liangbiao Hu, Joseph J. Esposito
  • Patent number: 6241989
    Abstract: The present invention relates to multivalent recombinant raccoon poxviruses, containing more than one exogenous gene inserted into either the thymidine kinase gene, the hemagglutinin gene, or a combination thereof. Disclosed is the use of the multivalent recombinant raccoon poxviruses as vaccines to immunize felines against subsequent challenge by feline pathogens. Also disclosed is a method of making a a multivalent recombinant raccoon poxvirus by a recombination process involving the construction of an insertion vector into which the exogenous genes are inserted, and flanking the inserted genes are sequences which can recombine into the raccoon poxvirus thymidine kinase gene, or the hemagglutinin gene, or a combination thereof; introducing both the insertion vector containing the exogenous genes, and raccoon poxvirus into susceptible host cells; and selecting the recombinant raccoon poxvirus from the resultant plaques.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: June 5, 2001
    Assignees: Cornell Research Foundation, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Fred W. Scott, Christopher K. Ngichabe, Liangbiao Hu, Joseph J. Esposito
  • Patent number: 5348741
    Abstract: A plasmid vector has been constructed for producing unique vaccinia virus recombinant expressing the gene for rabiesvirus glycoprotein in cells. The recombinant induces production of glycoprotein in substantial amounts for immunization against rabies. Such recombinant could be applied for the production of anti-rabies vaccine and of G antigen antibody and related immunological reagents for research or diagnostic purposes.
    Type: Grant
    Filed: September 14, 1992
    Date of Patent: September 20, 1994
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Joseph J. Esposito, Bernard Moss, Kathleen Brechling
  • Patent number: 5266313
    Abstract: Raccoon poxvirus, an organism that may be indigenous in nature, is established as a suitable substrate for insertion and expression of nucleotide coding sequence of heterolgous organisms. Two infectious raccoon poxvirus recombinants for expressing rabies virus surface spike glycoprotein (G) were produced by homologous recombination between raccoon poxvirus DNA and chimeric plasmids previously used for production of vaccinia virus recombinants by thymidine kinase insertional inactivation. Raccoons that were fed polyurethane baits loaded with raccoon poxvirus recombinant quickly developed high levels of rabies virus neutralizing antibodies and were protected when challenged with an otherwise lethal dose of raccoon rabies street virus. Dogs developed rabies virus neutralizing antibodies after feeding a vectored raccoon poxvirus recombinant in contrast to feeding a vaccinia: G recombinant that induced no rabies neutralizing antibodies.
    Type: Grant
    Filed: February 3, 1992
    Date of Patent: November 30, 1993
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Joseph J. Esposito, George M. Baer